Evinova & Harbour BioMed Partner on AI-Enabled Drug Development
Yesterday, in the course of the eighth China International Import Expo (“CIIE”), Evinova, a worldwide health-tech firm accelerating the supply of higher well being outcomes by propelling the life sciences sector ahead in digital well being, and Harbour BioMed (HKEX: 02142), a worldwide biopharmaceutical firm dedicated to the invention and improvement of novel antibody therapeutics…
